Mitchell S. Analyst Performance

Biotech Analyst at HC Wainwright

Mitchell S. is a stock analyst at HC Wainwright focused in the medical sector, covering 29 publicly traded companies. Over the past year, Mitchell S. has issued 105 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S.'s coverage history, rating activity, and performance tendencies â€” helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 105 Last 0 Years
Buy Recommendations: 86.67% 91 Buy Ratings
Companies Covered: 29 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	86.7%	91 ratings
Hold	8.6%	9 ratings
Sell	4.8%	5 ratings

Out of 105 total stock ratings issued by Mitchell S. at HC Wainwright, the majority (86.7%) have been Buy recommendations, followed by 8.6% Hold and 4.8% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	96.6% of companies on NASDAQ	28 companies
NYSE	3.4% of companies on NYSE	1 company

Mitchell S., an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 27 companies	93.1%
	Manufacturing 2 companies	6.9%

Mitchell S. of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 17 companies	58.6%
MED - DRUGS 9 companies	31.0%
Miscellaneous 2 companies	6.9%
PHARMACEUTICAL PREPARATIONS 1 company	3.4%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
ALMS Alumis	5/15/2026	Downgrade	$24.63	$25.00	Neutral
KYTX Kyverna Therapeutics	5/15/2026	Boost Price Target	$10.74	$25.00	Buy
TYRA Tyra Biosciences	5/14/2026	Reiterated Rating	$36.18	$45.00	Buy
AVTX Avalo Therapeutics	5/14/2026	Lower Price Target	$19.85	$35.00	Buy
NTLA Intellia Therapeutics	5/13/2026	Lower Price Target	$13.99	$25.00	Buy
RNAC Cartesian Therapeutics	5/12/2026	Lower Price Target	$8.53	$25.00	Buy
CTMX CytomX Therapeutics	5/11/2026	Lower Price Target	$3.98	$11.00	Buy
GENB Generate Biomedicines	5/8/2026	Boost Price Target	$13.59	$25.00	Buy
BMRN BioMarin Pharmaceutical	5/5/2026	Reiterated Rating	$55.46	$55.00	Neutral
INCY Incyte	5/4/2026	Reiterated Rating	$96.91	$135.00	Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
SMMT Summit Therapeutics	5/4/2026	Lower Price Target	$16.11	$23.00	Buy
IONS Ionis Pharmaceuticals	4/30/2026	Boost Price Target	$74.83	$125.00	Buy
ORKA Oruka Therapeutics	4/29/2026	Boost Price Target	$73.99	$120.00	Buy
HALO Halozyme Therapeutics	4/29/2026	Boost Price Target	$63.86	$95.00	Buy
KYTX Kyverna Therapeutics	4/23/2026	Reiterated Rating	$10.23	$20.00	Buy
LEGN Legend Biotech	4/21/2026	Reiterated Rating	$25.07	$50.00	Buy
SRPT Sarepta Therapeutics	4/16/2026	Reiterated Rating	$21.07		Sell
LEGN Legend Biotech	4/15/2026	Reiterated Rating	$18.69	$50.00	Buy
INCY Incyte	4/15/2026	Reiterated Rating	$97.69	$135.00	Buy
ORKA Oruka Therapeutics	4/13/2026	Boost Price Target	$59.58	$70.00	Buy
GENB Generate Biomedicines	4/13/2026	Initiated Coverage	$11.41	$16.00	Buy
ALMS Alumis	3/30/2026	Lower Price Target	$24.80	$25.00	Buy
PALI Palisade Bio	3/26/2026	Initiated Coverage	$2.00	$7.00	Buy
INCY Incyte	3/25/2026	Reiterated Rating	$90.62	$135.00	Buy
AVTX Avalo Therapeutics	3/25/2026	Boost Price Target	$13.45	$40.00	Buy
IONS Ionis Pharmaceuticals	3/25/2026	Boost Price Target	$73.05	$120.00	Buy
EVMN Evommune	3/18/2026	Lower Price Target	$24.99	$50.00	Buy
CTMX CytomX Therapeutics	3/16/2026	Boost Price Target	$7.81	$17.00	Buy
INCY Incyte	3/9/2026	Reiterated Rating	$95.94	$135.00	Buy
NTLA Intellia Therapeutics	3/3/2026	Boost Price Target	$15.44	$30.00	Buy
SRPT Sarepta Therapeutics	3/2/2026	Reiterated Rating	$16.76		Sell
CBIO Crescent Biopharma	3/2/2026	Lower Price Target	$12.09	$22.00	Buy
BMRN BioMarin Pharmaceutical	2/25/2026	Lower Price Target	$62.62	$55.00	Neutral
SMMT Summit Therapeutics	2/24/2026	Lower Price Target	$16.09	$30.00	Buy
TYRA Tyra Biosciences	2/17/2026	Boost Price Target	$27.99	$45.00	Buy
INCY Incyte	2/11/2026	Reiterated Rating	$100.05	$135.00	Buy
EVMN Evommune	2/10/2026	Boost Price Target	$25.02	$65.00	Buy
SMMT Summit Therapeutics	2/2/2026	Reiterated Rating	$14.48	$40.00	Buy
HALO Halozyme Therapeutics	1/29/2026	Reiterated Rating	$71.70		Buy
NTLA Intellia Therapeutics	1/28/2026	Boost Price Target	$14.83	$25.00	Buy
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today. Download your copy now.
SRPT Sarepta Therapeutics	1/27/2026	Reiterated Rating	$22.80		Sell
LEGN Legend Biotech	1/22/2026	Lower Price Target	$20.76	$50.00	Buy
AVTX Avalo Therapeutics	1/15/2026	Reiterated Rating	$16.19	$25.00	Buy
SMMT Summit Therapeutics	1/14/2026	Reiterated Rating	$16.81		Buy
SRPT Sarepta Therapeutics	1/14/2026	Reiterated Rating	$21.46		Sell
LXEO Lexeo Therapeutics	1/13/2026	Lower Price Target	$8.12	$10.00	Buy
NGNE Neurogene	1/13/2026	Reiterated Rating	$17.28	$70.00	Buy
ALMS Alumis	1/9/2026	Reiterated Rating	$18.18	$40.00	Buy
TIL Instil Bio	1/7/2026	Reiterated Rating	$7.03		Neutral
BMRN BioMarin Pharmaceutical	12/22/2025	Boost Price Target	$61.15	$60.00	Neutral
HALO Halozyme Therapeutics	12/19/2025	Reiterated Rating	$65.11	$90.00	Buy
ALMS Alumis	12/18/2025	Boost Price Target	$11.03	$20.00	Buy
LYEL Lyell Immunopharma	12/9/2025	Upgrade	$28.36	$45.00	Buy
HALO Halozyme Therapeutics	11/28/2025	Reiterated Rating	$72.66	$90.00	Buy
LEGN Legend Biotech	11/26/2025	Reiterated Rating	$28.19		Buy
RNAC Cartesian Therapeutics	11/19/2025	Lower Price Target	$7.62	$30.00	Buy
NGNE Neurogene	11/13/2025	Boost Price Target	$31.08	$70.00	Buy
KRRO Korro Bio	11/13/2025	Reiterated Rating	$31.42		Neutral
CTMX CytomX Therapeutics	11/11/2025	Boost Price Target	$4.19	$10.00	Buy
NTLA Intellia Therapeutics	11/10/2025	Lower Price Target	$9.52	$15.00	Buy
IONS Ionis Pharmaceuticals	11/10/2025	Boost Price Target	$73.55	$110.00	Buy
LXEO Lexeo Therapeutics	11/3/2025	Reiterated Rating	$9.01		Buy
NGNE Neurogene	10/31/2025	Boost Price Target	$33.14	$65.00	Buy
IONS Ionis Pharmaceuticals	10/30/2025	Boost Price Target	$73.46	$100.00	Buy
NTLA Intellia Therapeutics	10/27/2025	Lower Price Target	$14.48	$25.00	Buy
ORKA Oruka Therapeutics	10/27/2025	Lower Price Target	$27.25	$40.00	Buy
KYTX Kyverna Therapeutics	10/27/2025	Boost Price Target	$7.44	$20.00	Buy
BMRN BioMarin Pharmaceutical	10/27/2025	Lower Price Target	$52.67	$55.00	Neutral
HALO Halozyme Therapeutics	10/21/2025	Reiterated Rating	$66.47		Buy
SMMT Summit Therapeutics	10/21/2025	Lower Price Target	$20.03	$40.00	Buy
LXEO Lexeo Therapeutics	10/21/2025	Lower Price Target	$9.22	$13.00	Buy
LEGN Legend Biotech	10/17/2025	Lower Price Target	$32.36	$60.00	Buy
HALO Halozyme Therapeutics	10/15/2025	Reiterated Rating	$66.65	$90.00	Buy
NGNE Neurogene	10/9/2025	Reiterated Rating	$28.20	$45.00	Buy
IONS Ionis Pharmaceuticals	10/8/2025	Reiterated Rating	$68.94	$95.00	Buy
LXEO Lexeo Therapeutics	10/7/2025	Boost Price Target	$8.42	$15.00	Buy
HALO Halozyme Therapeutics	10/2/2025	Boost Price Target	$74.94	$90.00	Buy
CRSP CRISPR Therapeutics	9/23/2025	Reiterated Rating	$62.10	$80.00	Buy
IONS Ionis Pharmaceuticals	9/23/2025	Reiterated Rating	$61.36	$95.00	Buy
HALO Halozyme Therapeutics	9/22/2025	Boost Price Target	$77.81	$85.00	Buy
NTLA Intellia Therapeutics	9/19/2025	Boost Price Target	$16.11	$30.00	Buy
SMMT Summit Therapeutics	9/16/2025	Reiterated Rating	$18.94	$50.00	Buy
TIL Instil Bio	9/11/2025	Reiterated Rating	$24.16	$125.00	Buy
SMMT Summit Therapeutics	9/8/2025	Reiterated Rating	$25.98	$50.00	Buy
BMRN BioMarin Pharmaceutical	9/8/2025	Initiated Coverage	$57.77	$60.00	Neutral
EDIT Editas Medicine	9/5/2025	Reiterated Rating	$2.52	$5.00	Buy
SMMT Summit Therapeutics	9/2/2025	Reiterated Rating	$23.70	$50.00	Buy
IONS Ionis Pharmaceuticals	9/2/2025	Boost Price Target	$42.63	$95.00	Buy
SMMT Summit Therapeutics	8/27/2025	Boost Price Target	$26.98	$50.00	Buy
CBIO Crescent Biopharma	8/27/2025	Reiterated Rating	$14.47	$25.00	Buy
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
TIL Instil Bio	8/27/2025	Reiterated Rating	$28.41	$125.00	Buy
SRPT Sarepta Therapeutics	8/25/2025	Reiterated Rating	$20.22		Sell
IONS Ionis Pharmaceuticals	8/22/2025	Boost Price Target	$43.24	$70.00	Buy
TYRA Tyra Biosciences	8/22/2025	Reiterated Rating	$11.70	$30.00	Buy
MGX Metagenomi	8/19/2025	Reiterated Rating	$1.92	$7.00	Buy
ZURA Zura Bio	8/19/2025	Lower Price Target	$1.74	$2.00	Neutral
ORKA Oruka Therapeutics	8/18/2025	Reiterated Rating	$15.37	$45.00	Buy
LXEO Lexeo Therapeutics	8/15/2025	Lower Price Target	$4.79	$9.00	Buy
TIL Instil Bio	8/15/2025	Reiterated Rating	$28.25	$125.00	Buy
SMMT Summit Therapeutics	8/15/2025	Reiterated Rating	$26.45	$44.00	Buy
ALMS Alumis	8/14/2025	Reiterated Rating	$4.42	$14.00	Buy
KRRO Korro Bio	8/13/2025	Lower Price Target	$15.99	$90.00	Buy
CBIO Crescent Biopharma	8/11/2025	Initiated Coverage	$12.85	$25.00	Buy
BOLD Boundless Bio	8/11/2025	Lower Price Target	$1.10	$4.00	Buy
NTLA Intellia Therapeutics	8/8/2025	Lower Price Target	$11.46	$25.00	Buy

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.